Federated Hermes’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-121
Closed -$7K 2214
2021
Q3
$7K Buy
+121
New +$5.68K ﹤0.01% 2016
2021
Q1
Sell
-114
Closed -$2K 2243
2020
Q4
$2K Buy
114
+68
+148% +$1.22K ﹤0.01% 2118
2020
Q3
$1K Buy
+46
New +$539 ﹤0.01% 2143
2018
Q2
Sell
-1
Closed -$1K 2208
2018
Q1
$1K Sell
1
-6,054
-100% -$235K ﹤0.01% 2091
2017
Q4
$258K Sell
6,055
-564
-9% -$24.2K ﹤0.01% 1477
2017
Q3
$284K Sell
6,619
-4,021
-38% -$151K ﹤0.01% 1452
2017
Q2
$394K Sell
10,640
-27,820
-72% -$1.23M ﹤0.01% 1429
2017
Q1
$2.08M Buy
38,460
+3,211
+9% +$167K 0.01% 895
2016
Q4
$1.87M Buy
35,249
+5,091
+17% +$290K 0.01% 897
2016
Q3
$1.83M Buy
30,158
+4,164
+16% +$259K 0.01% 884
2016
Q2
$1.71M Buy
+25,994
New +$1.65M 0.01% 904
2015
Q4
Sell
-7
Closed -$1K 2096
2015
Q3
$1K Buy
+7
New +$1.98K ﹤0.01% 1894

Other funds holding CLDX